Sphere-Forming Assays for Assessment of Benign and Malignant Pancreatic Stem Cells

Author(s):  
Yue J. Wang ◽  
Jennifer M. Bailey ◽  
Meritxell Rovira ◽  
Steven D. Leach
2013 ◽  
pp. 835-853 ◽  
Author(s):  
Juan Domínguez-Bendala ◽  
Antonello Pileggi ◽  
Camillo Ricordi

Author(s):  
Juan Domínguez-Bendala ◽  
Antonello Pileggi ◽  
Camillo Ricordi

PLoS ONE ◽  
2019 ◽  
Vol 14 (9) ◽  
pp. e0222350 ◽  
Author(s):  
Sophie G. Kellaway ◽  
Karolina Mosinska ◽  
Zainaba Mohamed ◽  
Alexander Ryan ◽  
Stephen Richardson ◽  
...  

2020 ◽  
Vol 21 (3) ◽  
pp. 991 ◽  
Author(s):  
Angelina Vladimirovna Pakhomova ◽  
Vladimir Evgenievich Nebolsin ◽  
Olga Victorovna Pershina ◽  
Vyacheslav Andreevich Krupin ◽  
Lubov Alexandrovna Sandrikina ◽  
...  

In clinical practice, the metabolic syndrome can lead to multiple complications, including diabetes. It remains unclear which component of the metabolic syndrome (obesity, inflammation, hyperglycemia, or insulin resistance) has the strongest inhibitory effect on stem cells involved in beta cell regeneration. This makes it challenging to develop effective treatment options for complications such as diabetes. In our study, experiments were performed on male C57BL/6 mice where metabolic disorders have been introduced experimentally by a combination of streptozotocin-treatment and a high-fat diet. We evaluated the biological effects of Bisamide Derivative of Dicarboxylic Acid (BDDA) and its impact on pancreatic stem cells in vivo. To assess the impact of BDDA, we applied a combination of histological and biochemical methods along with a cytometric analysis of stem cell and progenitor cell markers. We show that in mice with metabolic disorders, BDDA has a positive effect on lipid and glucose metabolism. The pancreatic restoration was associated with a decrease of the inhibitory effects of inflammation and obesity factors on pancreatic stem cells. Our data shows that BDDA increases the number of pancreatic stem cells. Thus, BDDA could be used as a new compound for treating complication of the metabolic syndrome such as diabetes.


2002 ◽  
Vol 9 (6) ◽  
pp. 704-709 ◽  
Author(s):  
Ammon B. Peck ◽  
Janet G. Cornelius ◽  
Desmond Schatz ◽  
Vijayakumar K. Ramiya

2009 ◽  
Vol 191 (1) ◽  
pp. 116-125 ◽  
Author(s):  
Anna Emilia Petschnik ◽  
Philipp Ciba ◽  
Charli Kruse ◽  
Sandra Danner

2015 ◽  
Vol 362 (2) ◽  
pp. 379-388 ◽  
Author(s):  
Xin He ◽  
Wei Han ◽  
Shu-xian Hu ◽  
Ming-zhi Zhang ◽  
Jin-lian Hua ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document